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ABSTRACT 
Mutations in mtDNA are known to cause neuromuscular diseases and have been 
associated with several common age-associated diseases as well as being a 
contributor to the aging process. Despite their importance there are still important 
aspects of mtDNA inheritance and mtDNA mutations that remain unknown and need 
to be addressed. The aim of this thesis is to examine how mtDNA mutations behave 
in in vivo systems with regard to inheritance and distribution. A further aim is to 
investigate the phenotypic consequences of mtDNA mutations, specifically in the 
aging process. For this purpose we used mouse models and different approaches for 
DNA sequence analysis.   
Our group previously demonstrated that increased somatic mtDNA mutagenesis can 
cause premature aging in the mouse, thus providing the first experimental data for the 
involvement of mtDNA mutations in aging. This work was based on analysis of the 
mtDNA mutator mouse, which is a knock-in mouse model with increased mtDNA 
mutation load due to a proofreading deficiency of mitochondrial DNA polymerase 
(Polγ). The work presented in this thesis demonstrates that a significant proportion of 
mtDNA mutations are passed on via the maternal germline and expand clonally in the 
offspring to contribute significantly to the observed phenotypes. By performing a 
variety of mouse crosses to generate mice with different combinations of maternally 
inherited and somatic mtDNA mutations we found that even low levels of inherited 
mtDNA mutations can lead to premature aging phenotypes. These phenotypes could 
be rescued by reintroduction of wild-type mtDNA. Our findings show that clonal 
expansion of maternally transmitted mtDNA mutations can be an important factor in 
the aging process. This finding is very intriguing in light of recent findings that 
inherited heteroplasmy is common in humans. Furthermore, a combination of 
inherited and somatic mtDNA mutations can disturb development to cause stochastic 
brain malformations.  
There is a lack of understanding how pathogenic mtDNA mutations are inherited and 
studies in the area have been hampered by the lack of appropriate animal models. By 
backcrossing mtDNA mutator females we were able to isolate a mouse line carrying a 
single base pair deletion in the mitochondrial tRNAMet gene. Although this mutation 
was under selection in living offspring, we failed to observe any clear selection in 
germ cells and primary oocytes. The selection is instead occurring after fertilization 
as the embryo develops.  
Finally, we investigated the clonality of mtDNA inheritance. Mutations in mtDNA are 
the most commonly used marker in population genetics studies, and much of this 
popularity is based on the assumed lack of recombination in mtDNA. This assumption 
has now been questioned in a number of studies that report frequent recombination of 
mtDNA. In this thesis, I developed a novel direct cloning protocol to trap single 
mtDNA molecules, allowing for DNA sequence analysis without prior amplification by 
PCR. Applying this technique, there was no evidence for germline recombination of 
mtDNA in mice that has been heteroplasmic for >50 generations. 
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INTRODUCTION 
 
MITOCHONDRIA AND ORIGIN 
The blue print of life is DNA. The information stored within this molecule is used to 
create the bewildering variation of living organisms that populate our planet. In 
animals, DNA is found in two locations of the cell: the nucleus and the mitochondria. 
The majority of the DNA is in the nucleus and ~1 % in the mitochondria. Mitochondria 
are cellular organelles that are the generators of ATP, the energy currency of cells. 
These organelles have a bacterial origin, characterised by their circular genome, double 
membrane and their close relation to the α-proteobacteria (Burger, Gray & Lang, 1999; 
Andersson, Karlberg, Canbäck, et al., 2003). The eukaryotic cell evolved only once and 
as all eukaryotes have mitochondria (a few organisms have lost them secondarily) the 
organelle must have been present in the ancestral eukaryote (Lane, 2007). The 
prevalent hypothesis is that the mitochondria entered the proto-eukaryote about 2 
billion years ago by endophagocytosis. From this event a symbiotic relationship was 
established which proved to be extremely beneficial for both parts (Dyall, 2004). 
However, present benefits probably do not shed any light on the initial benefits. The 
popular notion is that the endosymbiont provided the host cell with ATP in the 
exchange for carbohydrates. This explanation does not hold up for closer scrutiny. 
Export and import of ATP has never been detected in free living bacteria and the 
ATP/ADP transport system found in present mitochondria has a eukaryotic origin 
(Andersson, Karlberg, Canbäck, et al., 2003). An alternative explanation has to do with 
the appearance of atmospheric oxygen. Two billion years ago, atmospheric oxygen 
content started to rise, creating a highly toxic environment for all anaerobic life. 
Therefore any possibility to lower local oxygen concentration would be highly 
adaptive. Similar to mitochondria, α-proteobacteria  utilize and consume oxygen during 
aerobic respiration. Hence, a possible benefit of the endosymbiont could have been that 
it provided its host with local reduction of oxygen content.  
 
MITOCHONDRIAL FUNCTION AND FORM 
 
Form  
A mitochondrion can be divided into four different compartments (Fig. 1): (i) the outer 
mitochondrial membrane, (ii) the inter-membrane space, (iii) the inner mitochondrial 
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membrane and (iv) the matrix. The outer membrane consists of a lipid bilayer and is 
semipermeable, allowing for diffusion of molecules <5Da in size. The inner 
mitochondrial membrane is impermeable and does not allow diffusion. The five 
complexes of the mitochondrial oxidative phosphorylation system are located in the 
inner membrane. The inner membrane is folded into invaginations, creating cristae. 
This is probably a way to increase its surface, allowing higher respiratory capacity per 
mitochondrion. Between these two membranes is the inter-membrane space. Enclosed 
by the inner membrane is the matrix, where mtDNA and mito-ribosomes are located.  
 
 
 
 
Figure 1. Schematic drawing showing the major components of the mitochondria. The 
mitochondrial respiratory chain (RC) is located in the inner mitochondrial membrane. The 
between 10^2-10^5 mtDNA molecules (depending on the cell type) are located in the matrix. The 
majority of the mitochondrial proteins are nuclear encoded and imported into the mitochondria.  
 
Mitochondria used to be regarded as single bean-shaped entities, but this model has 
been extensively modified in recent years. It is now widely accepted that mitochondria 
vary greatly in shape and size between different tissues (Kuznetsov, Hermann, Saks, et 
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al., 2009) and that they can alter their organization and morphology due to intra- and 
extra cellular signals (Seo, Joseph, Dutta, et al., 2010). Furthermore, mitochondria 
within an organism form a dynamic, constantly dividing and fusing network with a 
varying morphology (Chen & Chan, 2004). The system of fusion and fission is vital for 
mitochondrial function. Inhibition of fusion leads to loss of mtDNA (Chen & Chan, 
2010) and causes embryonic lethality in animals (Nunnari & Suomalainen, 2012).The 
functional significance of this system is still debated, but one explanation might be to 
achieve complementation between different mitochondria (Nakada, Sato & Hayashi, 
2009).  
 
Function 
Mitochondria take part in many important cellular functions, including controlled cell 
death by apoptosis (Smith, Ng, Kluck, et al., 2008) and calcium buffering (Rizzuto, de 
Stefani, Raffaello, et al., 2012). However mitochondria are most widely known for 
being the “powerhouse” of the cell, converting ADP to ATP by oxidative 
phosphorylation.  
Catabolism of sugars and fats generates reduced forms of the electron carriers NADH 
and FADH2. They deliver electrons to complex I and II of the mitochondrial electron 
transport chain (ETC). The ETC consists of four protein complexes, Complex I 
(NADH:ubiquinone oxidoreductase), III (ubiquinol-cytochrome c reductase) and IV 
(cytochrome c oxidase) are under dual genetic control (nDNA and mtDNA encoded 
proteins) while complex II (succinate:ubiquinone reductase) is built up only of nDNA 
encoded proteins. The electrons received by complex I and II are passed down the ETC 
in a tightly controlled series of redox reactions finally reducing oxygen to water. The 
energy released during the passage is used by complex I, III and IV to pump protons 
from the matrix into the inter-membrane space, creating an electrochemical proton 
gradient across the inner membrane. The protons are subsequently trans-located back 
into the matrix by passing through ATP-synthase. ATP-synthase is the final complex of 
the oxidative phosphorylation system, which consists of the four complexes of the ETC 
(complex I-IV) and ATP-synthase (complex V). ATP-synthase utilizes the proton 
gradient created by complex I, III and IV to combine ADP and phosphate into ATP, the 
energy currency of the cells.    
There are currently two competing models for how the complexes constituting the RC 
are structured in the inner mitochondrial membrane. The “fluid state” model describes 
the different complexes as autonomous entities that float freely in the membrane, 
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connected by the electron transporters cytochrome c and ubiquinone. The second model 
proposes that the complexes are stably associated, forming super-complexes. The 
support has shifted from the former to the latter as more evidence has been put forward 
in support for the existence and significance of super-complexes (Vartak, Porras & Bai, 
2013).   
 
mtDNA IN EUKARYOTES 
The genes of mtDNA are highly conserved among metazoan organisms and  encode 
proteins needed for aerobic respiration and ribosomal RNAs (Burger, Gray & Lang, 
2003). The first mitochondrial genome to be investigated was of mammalian origin. It 
was therefore initially thought that mtDNA always was circular and of modest size (15-
20 kb). It has over time become clear that this is not true and that a significant 
percentage of fungi and plants have huge mtDNA (up to 2Mb) with linear 
chromosomes (Burger, Gray & Lang, 2003). Interestingly, there is no correlation 
between mtDNA size and gene content (Andersson, Karlberg, Canbäck, et al., 2003) 
with the introduction of intragenic elements being the major factor behind the size 
increase in plants (Burger, Gray & Lang, 2003).  
mtDNA in eukaryotes tend to have between 12-20 protein coding genes and an 
additional number of tRNA and rRNA genes. The sharp reduction in gene number 
compared to their α-proteobacteria ancestors has been ascribed to at least two different 
processes: (i) loss of genes from the mtDNA as they were no longer needed in the new 
intracellular environment and/or became redundant as host genes of similar function 
existed and (ii) transfer of organelle genes to the nuclear genome. One intriguing 
question is why the mitochondrial genome has not been lost altogether. There seems to 
be a perfect co-segregation between the presence of mtDNA and a functional 
respiratory chain.  The mtDNA genes encoding cytochrome b and cytochrome c 
oxidase subunit I has been present in all organism surveyed so far (Park & Larsson, 
2011). Two different processes have been proposed to explain why mtDNA has been 
maintained: (i) the gene products of cytochrome b and cytochrome c oxidase are 
hydrophobic and difficult to transport into mitochondria or (ii) mtDNA is required to be 
in close proximity of the RC to regulate gene expression in relation to cellular energy 
demands (Park & Larsson, 2011). At present, 99% of the approximately 1500 
mitochondrial proteins are nDNA encoded and imported into the mitochondria 
(Andersson, Karlberg, Canbäck, et al., 2003; Nunnari & Suomalainen, 2012). The 
mitochondrial proteins are either of bacterial origin (~50%) or of eukaryotic origin 
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(~50%). These two groups are functionally divided, with genes of bacterial origin often 
encoding proteins involved in translation and respiration, whereas those of eukaryotic 
origin often are encoding regulatory factors and membrane proteins (Andersson, 
Karlberg, Canbäck, et al., 2003).  
 
mtDNA IN MAMMALS 
Mammalian mtDNA is a double stranded circular molecule that ranges from 15-20 kb 
in size (Fig. 2). The number of protein coding genes is well preserved among 
Metazoans, with variation in total gene number being mostly due to loss of tRNAs. In 
humans and mice, mtDNA is ~16.3 kb in size and harbors 37 genes. These genes 
encode 13 of the ~90 proteins of the mitochondrial RC plus 22 tRNAs and 2 rRNAs. 
  
 
Figure 2. Human/mouse mtDNA is a circular double stranded molecule ~16.5 Kb in size. It 
harbors 37 genes in total. The remaining ~1500 mitochondrial proteins are nuclear encoded. 
Complex I (ND1-ND6) is depicted in orange, complex III (CYTB) in red, complex IV (COXI-
COXIII) in green and complex V (ATP6 and ATP8) in blue. The ~1 kb non-coding D-loop is 
depicted in grey, tRNAs in green and the 2 ribosomal genes (12S and 16S rRNA) in yellow. All 
of the protein coding genes except ND6 are located on the H-strand. Also the majority of the 
tRNAs and the two rRNAs are located on the H-strand.  
 
The two individual strands of mtDNA are denoted heavy strand (H strand) and light 
strand (L strand) as they differ in guanine content and hence migrate differently in 
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alkaline cesium gradients (Larsson, 2010). The H strand harbors all of the protein 
coding genes (ND1-ND5, ND4L, CYTB, COXI-COXIII, ATP6 and ATP8), except 
ND6 which is located on the L strand. The majority of the tRNAs and the 2 rRNAs are 
located on the H strand (Fig. 2). The only major noncoding part of the mammalian 
mtDNA is  the D-loop, also termed the control region. The latter name refers to that the 
origin of replication of the leading strand and promoters for transcription of both 
strands are located within this part of the genome.  
 
IMPORTANT ASPECTS OF mtDNA GENETICS  
mtDNA differs from the nDNA in some important aspects: 
1. mtDNA is polyploid with multiple copies per cell and mitochondrion.  The 
number of copies varies depending on the cell type, ranging from 10^2 in 
sperm to 10^2 -10^4 in somatic cells and 10^5 in mature oocytes (Shoubridge & 
Wai, 2007). Some cells such as erythrocytes lack mtDNA altogether.  
2. The mtDNA molecules in a mitochondrion, cell or organism can all have the 
same DNA sequence, a state termed homoplasmy. However, the mtDNA 
population can also harbor a mixture of mtDNA molecules, a state termed 
heteroplasmy. Until recently the general notion was that humans were 
homoplasmic at birth (Taylor & Turnbull, 2005;Parsons, Muniec & Sullivan, 
1997). A number of studies have now questioned this model as NGS 
technology (Payne, Wilson, Yu-Wai-Man, et al., 2013;Li, Schönberg, 
Schaefer, et al., 2010) and denaturing gels (Tully, Parsons, Steighner, et al., 
2000) seems to show a low level heteroplasmy (~1%) universally among 
humans (Payne, Wilson, Yu-Wai-Man, et al., 2012).  It is estimated that 25 % 
of humans carry mtDNA mutations at heteroplasmy levels of 10 % or more 
(Li, Schönberg, Schaefer, et al., 2010). An alternative explanation to these 
findings could be the inherent high error rates of the NGS platforms (Schmitt, 
Kennedy, Salk, et al., 2012). However, the stringent controls applied in these 
studies together with the fact the other methodological approaches have given 
similar results (Tully, Parsons, Steighner, et al., 2000) argues against this 
explanation. 
3. There is continuous replication and turnover of mtDNA, even in post mitotic 
tissues such as heart and skeletal muscle (Larsson, 2010). Replication of 
mtDNA is not coupled to the cell cycle. This means that some mtDNA 
molecules may be replicated more than once and some not at all during a 
   7 
single round of cell division (Bogenhagen & Da Clayton, 1977). This can 
cause stochastic changes in heteroplasmy level within a cell, tissue and 
organism over time.    
4. mtDNA molecules are packed into protein aggregates called nucleoids within 
the mitochondrion. Estimates utilizing high resolution microscopy on 
mammalian cell lines have revealed that each nucleoid contains approximately 
one mtDNA molecule (Kukat, Wurm, Spåhr, et al., 2011). 
5. mtDNA is maternally inherited in mammals, though some exceptions have 
been reported in the literature. 
 
mtDNA INHERITANCE 
Maternal inheritance of mtDNA was first demonstrated by RLFP analysis in humans 
(Giles, Blanc & Cann, 1980). This is the general inheritance pattern among animals. 
There are however exceptions. Certain bivalves males have maternal mtDNA in the 
soma but paternal mtDNA in the germ cells (Ladoukakis & Zouros, 2001). It is 
sometimes stated that the exclusion of paternal mtDNA during inheritance is due to the 
fact that mtDNA of sperm do not enter the oocyte during fertilization. This is true for 
some animals, such as tunicates. In mammals, sperm mitochondria do enter the oocyte, 
but are then degraded by an incompletely understood mechanism (Rokas, Ladoukakis 
& Zouros, 2003). It has been observed that mitochondria in sperm become 
ubiquitinated during spermatogenesis (Sutovsky, DMoreno, Ramalho-Santos, et al., 
2000). Ubiquitination is a marker for proteolytic degradation. The strict maternal 
inheritance can however brake down under some circumstances. In inter-specific 
crosses of mice the selective destruction of paternally inherited mitochondria seems to 
fail, resulting in transmission of low amounts of paternal mitochondria to the offspring 
(Kaneda, Hayashi & Takahama, 1995;Gyllensten, Wharton, Josefsson, et al., 1991). 
This process has been termed paternal leakage. The rate of paternal leakage has not 
been studies extensively, but the few studies conducted in this field has reported 
frequencies ranging between 10^-3 – 10^-4 per fertilization (Rokas, Ladoukakis & 
Zouros, 2003). 
During transmission between generations the mtDNA pool in the maternal germline is 
passing through a physical and/or genetic bottleneck. The bottleneck hypothesis was 
put forward about thirty years ago after observing rapid shifts of mtDNA variants over 
just a few generations in cows (Olivo, Walle, Laipis, et al., 1983). The observation that 
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most mtDNA polymorphisms in organisms tend to be found between individuals and 
not within individuals also imply rapid segregation. Mitochondria cannot be made de 
novo, but have to be elaborated from existing mitochondria. Hence, all mitochondria in 
a mammal are derived from those in the mother´s oocyte. Studies using qPCR (Wai, 
Teoli & Shoubridge, 2008) and mathematical modeling (Jenuth, Peterson, Fu, et al., 
1996) have shown that there is a sharp reduction in mtDNA copy number per cell 
during germline development in mice. A mouse oocyte contains approximately 10^5 
mtDNA molecules (Shoubridge & Wai, 2007). However, during the first 7 days of 
embryonic development mtDNA replication is halted (Thundathil, Filion & Smith, 
2005;Shoubridge & Wai, 2007). The result is that the mtDNA molecules present in the 
fertilized oocyte are allocated among the dividing cells, resulting in fewer and fewer 
mtDNA molecules per cell by each cell division. The germline is established within the 
developing embryo as a cluster of approximately 50 cells called primordial germ cells 
(PGCs).  The number of mtDNA molecules per PGC is low and has been estimated to 
range between 180-280 (Jenuth, Peterson, Fu, et al., 1996;Wai, Teoli & Shoubridge, 
2008). Hence, during transmission only 0,01 % of the mitochondria in the fertilized 
oocyte contribute to the next generation (Shoubridge & Wai, 2007) creating a stark 
subsampling effect. The rapid segregation of mtDNA variants between generations has 
mostly been ascribed to this physical reduction in mtDNA copy number (Jenuth, 
Peterson, Fu, et al., 1996;Cree, Samuels, de Lopes, et al., 2008). An alternative 
explanation has been put forward, ascribing the segregation of mtDNA variants to 
replication of a subsample of mtDNA molecules during germline development (Wai, 
Teoli & Shoubridge, 2008).    
 
mtDNA REPLICATION AND REPAIR 
 
Replication 
Replication of mtDNA is strictly dependent on nDNA encoded proteins. Hence, all 
proteins needed for mtDNA replication and maintenance are imported from the cytosol 
into the mitochondria. The polymerase responsible for mtDNA replication is DNA 
polymerase γ (Polγ). Of the 16 identified eukaryotic DNA polymerases this is the only 
one that has been detected in mitochondria (Graziewicz, Longley & Copeland, 2006). 
Polγ consists of a catalytic subunit - having a 3´-5´exonuclease activity - and an 
accessory subunit required for processivity. The exonuclease activity can degrade 
single-stranded DNA and show a preference for 3´mismatches (Kaguni & Olson, 
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1989). This activity is critically dependent on conserved amino acid residues. Mutating 
these residues in yeast (Foury, S & Vanderstraeten, 1992) and mice (Trifunovic, 
Wredenberg, Falkenberg, et al., 2004) resulted in an increase in mtDNA mutations, 
clearly showing the importance of the exonuclease activity for mtDNA integrity 
(Longley, 2001).  
Other known proteins relevant for mtDNA replication include: mtSSB (binds single 
stranded DNA and stimulates Polγ activity), mtDNA helicase Twinkle (separates the 
two DNA strands during replication), topoisomerases (alter the topology of mtDNA by 
creating reversible breaks in the phosphordiester DNA backbone) and RNase H with a 
possible role in removal of RNA primers (Kasiviswanathan, Collins, Copel, et al., 
2012).   
To date three different models of mtDNA replication have been proposed: (i) an 
asynchronous strand displacement model (Clayton, 1991), (ii) a strand coupled 
bidirectional model (Holt, Lorimer & Jacobs, 2000), and (iii) a version of the strand 
coupled model termed RITOLS (RNA Incorporated Through Lagging Strand) (Yang, 
Bowmaker, Reyes, et al., 2002). In the first proposed model, initiation of mtDNA 
replication is dependent on the creation of a short RNA primer generated by a 
prematurely terminated transcript from LSP within the control region. In mitochondria, 
transcription and replication are tightly coupled processes. However, the models then 
differ in how they propose that mtDNA replication proceeds. 
The asynchronous strand displacement model was proposed by studying replication 
intermediates by EM and biochemistry. It postulates that after approximately 70% of 
the H-strand has been replicated, OriL is exposed and L-strand replication can initiate 
in the opposite direction. The strand coupled bidirectional model is based on findings 
from 2D gels, depicting replication intermediates with shapes indicative of replication 
forks (Holt, Lorimer & Jacobs, 2000). These replication intermediates were reported to 
be resistant to nucleases digesting single stranded DNA, consistent with duplex 
replication intermediates (Holt, Lorimer & Jacobs, 2000). Further analysis of these 
replication intermediates - using antibodies specific for RNA/DNA hybrids showed the 
presence of RNA in mtDNA, leading to the proposal of the RITOLS model of 
replication (Yang, Bowmaker, Reyes, et al., 2002). 
To date, there is no consensus whether these three proposed  modes of replication are 
all true in vivo and whether one of them is the dominating mode of mtDNA replication. 
Three of the proteins involved in mtDNA replication (Polg, Polrmt and Twinkle) are 
derived from bacteriophages (Shutt & Gray, 2006). In bacteriophages, the mode of 
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DNA replication switches during different stages of phage infection. It is therefore not 
unrealistic to presume that switching in mode of DNA replication also takes place in 
mitochondria. However, findings that it is possible to initiate replication from OriL in 
vitro (Fusté, Wanrooij, Jemt, et al., 2010) and that it is impossible to mutate some 
nucleotide positions in OriL in vivo (Wanrooij, Fusté, Stewart, et al., 2012) lends 
support to the asynchronous strand displacement model as this is the only model in 
which OriL has a proposed function . Also, the high levels of mtSSB in mitochondria 
lends support to the asynchronous strand displacement model, as this is the only model 
generating longer stretches of single stranded DNA.  
 
Repair 
mtDNA used to be regarded as a naked molecule without any physical protection (such 
as histones in nDNA) and devoid of DNA repair mechanisms. This view has changed 
during the last decade. mtDNA has been shown to be packaged into protein structures 
called nucleoids and is covered with TFAM molecules (one TFAM molecule per 15-20 
bp, (Kukat, Wurm, Spåhr, et al., 2011). It has also been shown that mitochondria do 
have DNA repair mechanisms. Both short-patch base excision repair (Bogenhagen, 
1999; de Souza-Pinto,Wilson, Stevnsner, et al., 2008) and long-patch base excision 
repair (Zheng, Zhou, Guo, et al., 2008) have been identified in mammalian 
mitochondria. Both of these mechanisms include the removal of the damage base(s) by 
specific glycosylases and subsequent filling of the gap by Polγ. Long patch base 
excision repair needs the additional help of FEN-1 and DNA2 proteins in the process 
(Kasiviswanathan, Collins, Copel, et al., 2012). The other DNA repair mechanisms 
identified in nDNA are either not present in mtDNA or remain to be discovered 
(Larsson, 2010).   
 
mtDNA MUTATIONS AND DISEASES 
Mutations in the mitochondrial genome have been shown to cause different 
neuromuscular diseases. Pathogenic mtDNA mutations were first identified in 1988 
(Holt, Harding & Morgan-Hughes, 1988;Wallace, Singh, Lott, et al., 1988) and since 
then more than 400 disease causing mutations have been identified (Li, Schönberg, 
Schaefer, et al., 2010). Identification of disease causing mtDNA mutations came as a 
bit of a surprise as it was assumed that the polyploid nature of mtDNA should protect 
the cell against the deleterious effects of de novo mutations. Epidemiological studies 
have shown that diseases caused by mtDNA mutations have a prevalence of 1/5000 
   11 
(Chinnery, Johnson, Wardell, et al., 2000;Schaefer, McFarland, Blakely, et al., 2008) 
and that these mutations are present in 1/200 live births and occur de novo in 1/1000 
live births (Elliott, Samuels, Eden, et al., 2008). These mutations can show extreme 
variability in phenotypic expression (McFarland, Taylor & Turnbull, 2010) with the 
same mtDNA mutation resulting in different phenotypes in different individuals, 
implying that nuclear encoded genes play an important role in disease development. 
mtDNA mutations tend to be functionally recessive and need to reach a certain 
heteroplasmy level (60-90 % depending on the mutation) to cause a biochemical defect 
and disease (Larsson, 2010). There are however exceptions where low level 
heteroplasmic mutations can cause diseases (Dubeau, de Stefano, Zifkin, et al., 
2000;Sacconi, Salviati, Nishigaki, et al., 2008). Furthermore, due to the mitochondrial 
bottleneck, pathogenic mutations can segregate to very different heteroplasmy levels in 
the offspring. Hence, a mother carrying a pathogenic mutation can give birth to both 
severely sick and healthy children. To date there is no way to counsel prospective 
mothers carrying pathogenic mtDNA mutations whether their children will be healthy 
or develop mitochondrial disease (Freyer, Cree, Mourier, et al., 2012).  
 
mtDNA MUTATIONS AND AGING 
Aging is commonly defined as a progressive and generalized impairment of cellular 
function, resulting in an increasing vulnerability to environmental challenge and a 
growing risk of disease and death of the organism (Kirkwood, 2005). Genetics has a 
clear role in aging as demonstrated by the different lifespans of animals in captivity, the 
heritability of human longevity and the possibility to select for long lived mutants in 
model organisms (Kirkwood, 2005). A positive correlation between increasing age, 
number of dysfunctional mitochondria and mtDNA mutation load has been found in a 
variety of organisms, implicating mtDNA mutations in the aging process (Larsson, 
2010). It was initially thought that the polyploid nature of mtDNA would protect the 
mitochondria against deleterious effect of de novo mutations. However, it was later 
shown that there is a decline of mitochondrial respiratory function with age (Trounce, 
Byrne & Marzuki, 1989) and that heart and muscle fibers in humans develop a mosaic 
pattern of respiratory chain deficient cells (Müller-Höcker, 1989;Müller-Höcker, 1990) 
with 30-60 % of skeletal muscle fibers in aged humans and monkeys containing 
respiratory deficient segments (Bua, Johnson, Herbst, et al., 2006;Pak, Herbst, Bua, et 
al., 2003). These respiratory deficient cells tend to co-localize with mtDNA deletions in 
both rats, monkeys and humans (Larsson, 2010). mtDNA point mutations generally 
 
 12 
accumulate in colonic crypts and ~15 % of all crypts in aged humans show respiratory 
dysfunction (Taylor, Barron, Borthwick, et al., 2003). Hence, a great number of 
correlative studies support the involvement of mtDNA mutations in the aging process.  
It was initially hypothesized that the observed increase in mtDNA mutation load with 
age was due to the accumulation of somatically generated mutations. An alternative 
explanation proposed is the clonal expansion of somatic mtDNA mutations generated 
during embryonic development (Larsson, 2010). A further possibility is that these 
mutations are not generated somatically at all, but rather inherited via the maternal 
germline to expand clonally during life. This hypothesis seems quite plausible in light 
of recent findings that heteroplasmy is universal among humans and that a great 
proportion of these mutations seem to have been passed on via the maternal germline 
(Payne, Wilson, Yu-Wai-Man, et al., 2012). 
 
THE mtDNA MUTATOR MOUSE 
The mtDNA mutator mouse was developed to experimentally address the involvement 
of mtDNA mutations in aging (Trifunovic, Wredenberg, Falkenberg, et al., 2004; 
Kujoth, Hiona, Pugh, et al., 2005). This is a knock-in mouse where an amino acid 
residue critical for the exonuclease activity of Polγ has been changed from an aspartic 
to an alanine. This results in a drastically impaired proof reading function of Polγ. The 
mutator mice are born in mendelian proportions and have a normal phenotype at birth 
(Trifunovic, Wredenberg, Falkenberg, et al., 2004; Kujoth, Hiona, Pugh, et al., 2005). 
However, at 175-270 days of age they begin to develop a progeroid phenotype with 
alopecia, kyphosis, anemia, reduced fertility, heart disease and decreased spontaneous 
movement (Trifunovic, Wredenberg, Falkenberg, et al., 2004; Kujoth, Hiona, Pugh, et 
al., 2005). This occurs concomitantly with an increase in number of respiratory chain 
deficient cells in liver and heart. Interestingly, no increase in ROS production was 
detected in these mice, but an increase in apoptosis was observed (Trifunovic, Hansson, 
Wredenberg, et al., 2005). The same pattern - with increased apoptosis but not ROS 
production - has been observed in other mouse models with respiratory chain 
dysfunction (Trifunovic, Wredenberg, Falkenberg, et al., 2004). The median and 
maximal life span of the mice is 336-416 and 430-460 days, respectively (Trifunovic, 
Wredenberg, Falkenberg, et al., 2004;Kujoth, Hiona, Pugh, et al., 2005). Due to the 
proof reading deficiency of Polγ, mice homozygous  for the mutator allele (Polgmut/mut  ) 
have a 3-27 fold increase in mutation load compared to WT siblings and approximately 
30 % of the mtDNA molecules are linear molecules with deletions (Trifunovic, 
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Wredenberg, Falkenberg, et al., 2004). The linear molecules with deletions seem to be 
a result of replication stalling (Bailey, Cluett, Reyes, et al., 2009) as the deleted part 
consists of the minor arc between OriL and OriH. A third group of mutated molecules, 
in the form of circular molecules with deletions, have also been also been reported 
(Vermulst, Wanagat, Kujoth,  et al., 2008). 
The molecular mechanism behind the progeroid phenotype has been hotly debated 
(Vermulst, Wanagat & Loeb, 2009; Edgar, Larsson & Trifunovic, 2010; Edgar & 
Trifunovic, 2009) and claims have been put forward that either point mutations (Edgar, 
Shabalina, Camara, et al., 2009) or circular molecules with deletions (Vermulst, 
Wanagat, Kujoth,  et al., 2008) are the driving molecular force creating the aging 
phenotype. However, in light of current knowledge about mitochondrial genetics and 
biochemistry, arguments supporting that circular molecules with deletions are the 
causative factor are very weak. These molecules are found at extremely low 
heteroplasmy levels (Edgar, Shabalina, Camara, et al., 2009). Point mutations and 
deletions in mtDNA tend to be functionally recessive and need to reach a certain 
threshold level to cause a biochemical defect (60-90 % depending on the mutation). 
With a detection limit of 0,1 %, Edgar, Shabalina, Camara, et al., 2009 were unable to 
detect any circular deleted mtDNA molecules. Genetically modified mice carrying high 
levels either single (Inoue, Nakada, Ogura, et al., 2000) or multiple (Tyynismaa, 
Mjosund, Wanrooij, et al., 2005) deletions in mtDNA do not show premature aging. 
Furthermore, deletions tend to generate translational defects as one or more tRNAs 
often are removed by the deleted region. In contrast to this expectation, translation is 
unaffected in the mtDNA mutator mouse (Edgar, Shabalina, Camara, et al., 2009). 
Taken together these findings argue against that circular molecules with deletions have 
any role in causing the progeroid phenotype.  
The steady state levels of assembled mtDNA encoded RC complexes were much lower 
in the mutator than in WT mice (Edgar, Shabalina, Camara, et al., 2009). This 
deficiency in assembled RC complexes was not due to impaired protein synthesis as no 
decrease in transcription or translation was detected (Edgar, Shabalina, Camara, et al., 
2009). However, an increase in turnover of mtDNA encoded respiratory chain 
complexes was detected. A plausible explanation for the progressive respiratory 
dysfunction in the mutator mouse is thus that accumulation of point mutations in 
protein coding mtDNA genes generates mis-folded proteins. The misfolding prevents 
proper assembly and/or stability of the respirator chain complexes, leading to 
subsequent degradation and increased turnover.  
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mtDNA AND METHODOLOGY 
To date, there is no universally accepted method to identify and quantify the different 
types of mtDNA mutations that are associated with diseases and aging. What makes 
this measurement problematic (compared to nDNA) is the cellular organization of 
mtDNA. The polyploid nature of mtDNA means that mutations can be found at a wide 
range of levels. This is in stark contrast to nDNA where a mutation is either present on 
one or both copies of a gene. To complicate things further, mtDNA mutations can 
expand clonally in a cell or a cluster of cells. This has been documented during aging in 
various organisms (Wanagat, Cao, Pathare, et al., 2001; Bua, Johnson, Herbst, et al., 
2006; Pak, Herbst, Bua, et al., 2003). The result is that even though some cells carry a 
mutation at high heteroplasmy level, the mean level of that mutation in the tissue as a 
whole can be very low (Alex, Kraytsberg, Khrapko, et al., 2007). Hence, mtDNA 
mutation analysis involves the identification of homoplasmic to very low frequency 
mutations, which requires a highly stringent and precise method. Application of 
different methods to estimate the mutation load in the same tissue have systematically 
generated estimates that differ by 2-3 orders of magnitude (Alex, Kraytsberg, Khrapko, 
et al., 2007; Greaves, Beadle, Taylor, et al., 2009) clearly showing the current 
methodological shortcomings in mtDNA mutation analysis. This discrepancy may be 
due to many different factors, but one significant problem lies in that all methods have 
an inherent error rate, inducing different types of artifacts to varying degrees. This is a 
problem for mitochondrial research in general, but maybe most pronounced in 
mitochondrial aging research, investigating the role of mtDNA mutations in the aging 
process. A handful of methods are used for mtDNA mutation identification and 
quantification. Listed below are the most commonly used methods. The pros and cons 
associated with respective approach are also included. 
 
Sanger sequencing of PCR products 
This has been the gold standard technique for mtDNA mutation identification. Due to 
the initial PCR amplification step very little starting material is needed. Hence, a single 
cell can be sequenced and analyzed. However, a major limitation with the technique is 
the detection level. As the sequence data comes out as the mean signal strength per base 
pair, mutations with a heteroplasmy level of 20 % or less will not be detectable. This is 
a not a major problem for the identification of diseases causing mtDNA mutations, 
which tend to expand monoclonally to high heteroplasmy levels. However, it is a 
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significant limitation in aging research where many different mutations expand 
polyclonally within the organism. These mutations expand to high heteroplasmy levels 
within a single cell or a cluster of cells. This generates a low heteroplasmy level of the 
mutation in the tissue as a whole and unless DNA sequence analysis is carried out on 
single cells, heteroplasmy levels will be below the detection limit of Sanger 
sequencing.            
 
Sanger sequencing of cloned PCR products 
To circumvent the problems associated with the detection limit of conventional Sanger 
sequencing, cloned PCR products may instead be analyzed. This will generate sequence 
data on the single molecule level as each clone is derived from a single PCR amplicon. 
There are however limitations with this approach. The polymerase used during PCR 
amplification will introduce artifacts in the form of point mutations, deletions and 
chimeric molecules (Pääbo, Irwin & Wilson, 1990; Keohavong & Thilly, 1989). High 
fidelity polymerases have reported error rate of 6*10^-7 errors per bp per replication 
(Pavlov, Pavlova, Kozyavkin, et al., 2004). In an average PCR (20 cycles) this equals a 
final error rate of 1,2*10^-5 per bp. Another study report an error rate of 1,4*10^-5 error 
per bp (Smigrodzki, Parks & Parker, 2004). This is generally not a problem during 
standard Sanger sequencing as the frequency of most artificial mutations will be very 
low and hence not detectable. However, when cloning single PCR amplicons these 
artifacts will be present in all of the copies and will therefore be indistinguishable from 
true mutations.  
The most common way to test the error rate of a method is to pass a control DNA 
fragment through the entire experimental procedure and check for novel mutations. As 
the sequence of the control DNA is known, any novel mutations in the control DNA 
can be scored as errors introduced by the method.  The problem is, however, that 
control DNA templates differs from the cellular DNA templates in at least two ways 
that can affect the number of errors that are introduced. First, control DNA is often in 
the form of a high copy number plasmid. Therefor much less number of PCR cycles is 
needed to reach PCR plateau than when using a cellular DNA template (Alex, 
Kraytsberg, Khrapko, et al., 2007). This means that fewer artifacts will be introduced in 
the control DNA than in the cellular DNA. Secondly, cellular DNA often contains 
chemical modifications (for example 8-oxo-guanine and deaminated cytosine) that can 
be converted into mutations. The cloned control DNA is most likely devoid of chemical 
damage (Alex, Kraytsberg, Khrapko, et al., 2007). Taken together, these factors might 
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lead to an underestimation of the number of errors that are introduced in the cellular 
template. 
The error rate of a method will start to confound the data when it is on par with (or 
higher) than the mutation load being estimated. Hence the PCR and cloning method is 
well suited for mutation load estimates in organisms with higher mutation loads, but 
less suitable for estimating lower mutation loads.  
 
Single molecule PCR 
To circumvent the problems with artifacts in the PCR and cloning approach single 
molecule PCR (smPCR) was developed. The principle of this technique is that 
templates used in the PCR are diluted to such an extent that only each fifth well has a 
single DNA template (molecule) in it and generates a PRC product (Kraytsberg & 
Khrapko, 2005). This approach is very intellectually appealing. It would generate 
sequence data on single molecule level and would give the possibility to tell artificial 
and true mutations apart. However, there are some critical aspects regarding this 
method that have not been properly addressed. First, the idea that template dilution 
generates PCR reactions with a single DNA template has mostly been based on 
theoretical calculations and has not been experimentally verified in a satisfying way. 
Furthermore, it does not exclude the possibility of the presence of fragmented DNA 
templates in the reaction. Secondly, it has been reported that mtDNA exists in the form 
of catenated networks in some tissues of both mice and humans (Pohjoismäki & 
Goffart, 2011). So far the smPCR protocol has not reported to include any treatment of 
the mtDNA templates with endonuclease and/or topoisomerase prior to amplification. 
 
Random mutation capture 
One way of avoiding PCR induced artifacts is to conduct the screening for mutations 
prior to PCR amplification. The Random Mutation Capture (RMC) method is a 
restriction enzyme based method aimed at screening a large number of specific short 
DNA sequences for mutations prior to PCR amplification (Bielas & Loeb, 2005) 
(Vermulst, Wanagat, Kujoth,  et al., 2008). In short, the target sequence is cleaved with 
a restriction enzyme, followed by PCR amplification with primers annealing up- and 
downstream of the target sequence. As WT sequences will be cut, only mutated 
molecules will generate a PCR product. Hence, the number of PCR products can be 
used as an indicator for the number of mutated sites. As the number of mtDNA 
molecules screened has been quantified by qPCR, the mutation rate can be calculated. 
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There are however limitations with this method. The most critical, from a 
mitochondrial aging research perspective, is that it only screens for mutations within a 
specific target sequence, which is very limited in size (often only 4 bp). It has been 
documented that mutation accumulation varies between nucleotides positions in 
mtDNA (Stoneking, 2000) and that mtDNA mutations accumulate in a clonal fashion 
during aging (Larsson, 2010). Screening for mutations by RMC systematically 
generates lower mutation load estimates than with other methods (Greaves, Beadle, 
Taylor, et al., 2009; Alex, Kraytsberg, Khrapko, et al., 2007). This is most likely a 
consequence of the method, which misses mutations due to its restricted target 
sequence. This severely limits its application in mitochondrial aging research.   
 
Direct cloning 
The most stringent methodological approach to identify and quantify mtDNA 
mutations should be direct cloning (Edgar & Trifunovic, 2009; Alex, Kraytsberg, 
Khrapko, et al., 2007). As the cloning is performed by using non-amplified genetic 
material the problems associated with PCR - in the form of point mutations and 
artificial recombinant molecules - should be avoided to a great extent. The errors 
introduced by DNA replication should be few, as the DNA replication error rate in the 
vectors normally used for direct cloning has been estimated to be very low, 7.7*10^-8 to 
5.4*10^-10 errors per bp (Drake, Charlesworth, Charlesworth, et al., 1998). Furthermore, 
it should also be possible to differentiate between artificial mutations and true 
mutations. As the sequence data is based on a single molecule, artifacts introduced 
either by vector DNA replication or by any downstream reaction should show up as 
heteroplasmies in the sequence data and can thus be discarded (Kraytsberg & Khrapko, 
2005). Direct cloning should therefore be a suitable methodological approach to 
estimate mutation load in organisms with a low mutation load.  However, direct cloning 
of human and mouse mtDNA has proven difficult (Yonemura, Nakada, Sato, et al., 
2007; Bigger, Tolmachov, Collombet, et al., 2000). The use of bacterial vectors have 
nevertheless proven successful in direct cloning of mtDNA in a few occasions (Bigger, 
2003; Yonemura, Nakada, Sato, et al., 2007) but it demanded a lot of starting material 
and gave a low yield in the form of few clones  In summary, direct cloning, albeit 
sometimes labor intensive, offers one of the more error free and least biased ways of 
analyzing mtDNA mutations.     
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Next generation sequencing 
The appearance of next generation sequencing (NGS) platforms offers an opportunity 
to screen for mtDNA mutations at a depth that has not previously been possible. These 
platforms are all based on parallel amplification and sequencing of millions of single 
DNA molecules, generating data in the order of 10^10 bp, all on single molecule level. 
In theory, this should enable identification of single molecules and unique mutations 
when sequencing at a sufficient depth. However, all of the NGS platforms have a high 
inherent error rate which has up until recently effectively hindered their application for 
identification of low level mutations. The unfiltered error rate of the Illumina platform 
has been reported to be as high as 11 % per sequenced bp (Li, Schönberg, Schaefer, et 
al., 2010) whereas the error rate of the SOLiD platform has been reported to 0,075 % 
per sequenced bp (Tolmachov & Collombet, 2012). The error rate after applying 
different quality filters varies between 0,005-0.01 errors per sequenced bp depending 
on the platform used, read length, sequence context and the bp position in the amplicon 
(Kinde, Wu, Papadopoulos, et al., 2011; Li, Schönberg, Schaefer, et al., 2010). One 
additional step used to control for the high error rate is to sequence a control sample 
with a known sequence. All variants detected in the control sample can be regarded as 
method-induced errors. A control sample does not only allow identification of the 
background error rate, but can also be used to subtract the errors introduced to the 
actual sample. The generation of artificial mutations tends to be dependent on the DNA 
sequence and the nucleotide position (Li, Schönberg, Schaefer, et al., 2010) as well as 
the guanine-cytosine content (Payne, Wilson, Yu-Wai-Man, et al., 2012). By utilizing a 
control sample with similar DNA sequence to the actual sample, the mutations found in 
the former can be subtracted from the latter, and by this control for method-induced 
errors. A further step to control for errors that has proven useful is to score mutations as 
true events only if they are verified by reads from both strands. Mutations and errors 
tend to be sequence specific. Errors will therefore appear on one strand only whereas 
true mutations will be found on both strands. This approach has been show to lower the 
error rate 30 fold (Li, Schönberg, Schaefer, et al., 2010). An extension of double strand 
validation is to barcode each molecule with a unique id (Schmitt, Kennedy, Salk, et al., 
2012). Here, the double validation can be done both within the strand but also between 
the two strands of the very same molecule. According to the authors, this allows for 
identification of mutation with a mutation load of 10^-6 mutations per bp (Schmitt, 
Kennedy, Salk, et al., 2012). 
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In summary, the NGS platforms tend to have a high error rate, but when proper controls 
and quality filters are applied they can be used to screen for mtDNA mutations with 
low heteroplasmy levels.   
 
mtDNA AND RECOMBINATION 
Mutations in mtDNA are the most frequently used genetic markers depicting the 
evolution of humans but also other animals. This popularity rests upon three pillars: the 
high sequence divergence of mtDNA, the almost exclusive maternal transmission and 
the assumed lack of germline recombination. The two latter points mean that mtDNA is 
used as a molecular marker showing patterns of clonal inheritance and that an unbroken 
maternal phylogeny can be constructed. This inheritance pattern reduces the complexity 
of the analyses as biparental inheritance does not have to be taken into account. 
However, during the last two decades a number of reports have questioned the 
assumption that there is no mtDNA recombination based on analyses of  human 
population genetic sequence data (Hagelberg, Goldman, Lió, et al., 1999; Awadalla, 
Eyre-Walker & Smith, 1999), human patient tissues (Kraytsberg, Schwartz, Brown, et 
al., 2004; Zsurka, Kraytsberg, Kudina, et al., 2005), tissue culture cells (D’Aurelio, 
Gajewski & Lin, 2004; Fan, Lin, Potluri, et al., 2012) and tissues from interspecies 
animal hybrids (Ujvari, Dowton & Madsen, 2007). These findings could have far 
reaching implications, as even modest frequencies of germline recombination can affect 
coalescent time estimates and branch lengths in phylogenetic trees (Schierup & Hein, 
2000). Hence, if mtDNA does recombine, there might be a need to re-evaluate all 
studies where this marker has been used.  
Today, there is a lack of compelling data either for or against mtDNA recombination in 
the mammalian germline. This stems from a combination of methodological limitations 
and the lack of appropriate in vivo experimental systems to address this important issue. 
This has left the research field in uncertainty, with claims both for and against 
recombination being questioned. The type of tests commonly used to screen for 
recombination can be divided into direct and indirect tests. Listed below are the 
methodological approaches commonly used to screen for mtDNA recombination and 
the pros and cons associated with them.   
Indirect tests utilize population genetic data and screen for: (i) a negative correlation 
between linkage disequilibrium (LD) and physical distance (recombination breaks up 
linkage between mutations and the chance of this to occur increases with physical 
distance) or, (ii) an excess of homoplasies within the data set. Homoplasies are  
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mutations that are identical, but not by descent. Finding a significant excess of 
homoplasies within different branches of a phylogenetic tree can be an indication of 
recombination (but alternative explanations exists, see below). The advantage of 
indirect tests is that one uses data covering many generations, hence investigating 
germline events. As somatic recombination is irrelevant to evolution and only germline 
recombination will affect the clonality of mtDNA inheritance, this is a very important 
point. The problems with indirect tests are, however, their low statistical power to 
detect recombination (Rokas, Ladoukakis & Zouros, 2003; Ladoukakis & Eyre-Walker, 
2004) and the presence of mutational hotspots in mtDNA. Mutational hotspots and 
uneven distribution of mutations can create the same pattern and distribution of genetic 
markers as recombination does. LD analysis (Awadalla, Eyre-Walker & Smith, 1999) 
and homoplasmy tests (Hagelberg, Goldman, Lió, et al., 1999) were used in two 
publications that reported mtDNA recombination in the germline of humans and caused 
a great stir within the scientific community (Kivisild & Villems, 2000; Elson, Andrews, 
Chinnery, et al., 2001; Piganeau & Eyre-Walker, 2004; Bandelt, 2005). However, these 
studies did not hold up to closer scrutiny and the positive results for recombination 
turned out to be due to a miss alignment (Hagelberg, Goldman, Lió, et al., 1999) and 
the use of a too small sample size (Awadalla, Eyre-Walker & Smith, 1999). Hence, to 
date indirect tests have failed to produce any convincing evidence either for or against 
recombination (Elson & Lightowlers, 2006). 
Direct tests screen for recombinant molecules within an organism. For recombination 
to be detectable this needs to occur between mtDNA molecules with different DNA 
sequence. Hence, direct tests involve the identification of heteroplasmic organisms and 
subsequent screening for molecules that carry a mixture of the two mtDNA 
populations, indicating recombination. A number of studies applying direct tests have 
reported the presence of recombinant mtDNA molecules in humans (Zsurka, 
Kraytsberg, Kudina, et al., 2005; Kraytsberg, Schwartz, Brown, et al., 2004), model 
organisms (Sato, Nakada, Akimoto, et al., 2005; Ujvari, Dowton & Madsen, 2007), and 
cell lines (D'Aurelio, Gajewski & Lin, 2004; Fan, Lin, Potluri, et al., 2012). However, a 
significant limitation with direct tests is that they mostly cover somatic events which 
are irrelevant to evolution and the question of mtDNA clonality. A further matter that 
complicates the application of direct tests is homoplasies and genetic drift. 
Homoplasies can generate a distribution of mutations that is difficult to tell apart from 
recombination, especially when the mtDNA populations differ at a limited number of 
nucleotide positions. The loss of mtDNA haplotypes through genetic drift (termed 
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lineage extinction) makes identification of recombinant molecules difficult. If one of 
the ancestral haplotypes that constitutes a recombinant has been lost it will effectively 
hinder identification of the recombinant (Elson & Lightowlers, 2006). Furthermore, 
many of the studies applying direct tests have used sequencing of cloned PCR products 
to screen for recombinants. PCR does produce chimeric PCR products in vitro that can 
be falsely interpreted as evidence for in vivo recombination. Creation of artificial 
recombinants during PCR amplification when using a mixed population of templates 
has been robustly documented in nuclear encoded genes (Pääbo, Irwin & Wilson, 1990; 
Keohavong & Thilly, 1989). The most stringent study conducted so far applying direct 
test is the study by (Sato, Nakada, Akimoto, et al., 2005). In this paper direct cloning 
and sequencing of mtDNA molecules from a two heteroplasmic mouse lines was 
carried out. One of the mouse lines was heteroplasmic for a deletion causing respiratory 
deficiency and the other mouse line was heteroplasmic for neutral mtDNA genotypes. 
They detected ~1% recombinants in the respiratory deficient mouse line but no 
recombinants in the mouse line with neutral heteroplasmy. This finding may imply that 
maybe there is selection for somatic recombinants in the soma under mitochondrial 
dysfunction. However, one severe limitation of this study is that it almost exclusively 
investigates somatic events which, as said, are irrelevant for evolution and the question 
of the clonality of mtDNA inheritance. Hence, to date direct tests have not produced 
any convincing data either for or against mtDNA recombination in the germline of 
mammals.   
 
mtDNA AND SELECTION 
For a long time mtDNA was considered to be inherited in a neutral fashion, not affected 
by the forces of natural selection.  However, during the last two decades data 
accumulated indicating negative/purifying selection in mtDNA (Nachman, Brown & 
Stoneking, 1996; Nachman, 1998; Elson, Turnbull & Howell, 2004; Stewart, Freyer, 
Elson, et al., 2008; Fan, Waymire, Narula, et al., 2008). The nature of mtDNA 
sequence evolution has commonly been tested either by: (i) comparing the ratio of non-
synonymous (dN) to synonymous (dS) mutations per site in a population of organisms (a 
ratio of 1 equals neutral evolution and a value <1 indicates purifying selection) or (ii) 
by comparing the ratio of dN/dS per site within and between species (McDonald-
Kreitman test). If the DNA sequence evolves under neutral conditions this ratio should 
be the same within and between species. However, if purifying selection is acting upon 
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the DNA sequence there should be less dN mutations in the interspecific comparison 
than in the intraspecific comparison.  
Nachman (Nachman, Brown & Stoneking, 1996; Nachman, 1998) applied the 
McDonald-Kreitman test on mtDNA sequence data from humans, chimpanzees and 25 
different animal species to test the neutrality of mtDNA sequence evolution. The ratio 
of dN/dS per site was less between species than within them, indicating purifying 
selection. A similar approach was used by Elson, Turnbull & Howell (2004) to test the 
nature of mtDNA sequence evolution in humans. Also here a lack of dN mutations was 
observed over time.  
Stewart, Freyer, Elson, et al., 2008 obtained results showing signs of strong purifying 
selection against dN mutations in the mouse germline. To investigate this, maternal 
lineages were derived from the mtDNA mutator mouse to pass on a wide range of 
mtDNA mutations via the germline.  In the N2 generation there was an obvious lack of 
dN mutations. There were also fewer mutations in first and second codon positions than 
in third codon positions. Mutations in first and second codon positions tend to generate 
dN mutations but mutations in third codon positions tend to generate dS mutations. 
Thus, an excess of mutations in the third codon is a universal sign of purifying 
selection.  
Taken together, there is now ample evidence for selection against dN mutations in 
mtDNA in the germline of animals. Interestingly, the strength of selection even seems 
to be stronger in mtDNA than in nDNA. The dN /dS ratio can be used to estimate the 
strength of the selection (the lower the value, the stronger the selection). When dN /dS  
ratios were calculated for protein coding genes located in mtDNA and nDNA the ratios 
were much lower for the mtDNA encoded genes (Nabholz, Ellegren & Wolf, 2013). 
This is opposite to what the neutral theory of molecular evolution predicts and indicates 
that the purifying selection is stronger in mtDNA-encoded genes than in nDNA. 
There however seems to be little selection against pathogenic/dN mutations in the soma 
(Greaves, Elson, Nooteboom, et al., 2012). When comparing the mutational spectrum 
in human colonic crypts of aged individuals to the mutational spectrum found in the 
general population there was a general expansion of dN mutations in the aged samples 
(including many more frame shift and termination mutations), indicating relaxed 
selection pressure in the soma compared to the germline (Greaves, Elson, Nooteboom, 
et al., 2012). 
What has been observed is somatic selection for apparently neutral mtDNA genotypes. 
Mice artificially heteroplasmic for the NZB and BALB/c  mtDNA genotypes (Jenuth, 
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Peterson, Fu, et al., 1996) showed neutral segregation in the germline but tissue specific 
selection in the soma (Jenuth, Peterson & Shoubridge, 1997). Liver and kidney selected 
for the NZB genotype and blood and spleen for the BALB/c genotype. All other tissues 
showed no signs of selection. This segregation pattern do not depend on mitochondrial 
function or replication rates, but is modulated by nuclear encoded genes (Battersby, 
Loredo-Osti & Shoubridge, 2003)   
 
λ-PHAGE CLONING VECTOR 
λ-phage has been used as a cloning vector since the early 1970 (Murray & Murray, 
1974) and is one of the most well established systems for cloning DNA. The λ-phage is 
a bacteriophage which proliferates by infecting host bacteria. They attach to the 
maltoporin receptor of the membrane of the host bacteria and inject their DNA by the 
use of their tail tube. Upon entering the host the λ-phage can “choose” between two 
different paths: (i) entering lytic growth and active proliferation by continuous infection 
and lysing of host cells or (ii) to enter the lysogenic state, incorporating its genome into 
the host genome. By this pathway the phage genome is replicated together with the host 
genome and thus transmitted to progeny bacteria. The pathway “chosen” depends on 
the multiplicity of the infection and the nutritional state of the host bacterial. High 
multiplicity infection and bad nutritional state of the host bacteria favors the lysogenic 
state (Boyd, 1951). As lytic growth is required during λ-phage cloning the host bacteria 
used during cloning are grown on a rich medium.   
The λ-phage genome was one of the first to be fully sequenced (Sanger, Coulson, 
Hong, et al., 1982). The genome of WT λ-phage is a double stranded DNA molecule of 
48502 bp in size. The genome can be divided into three functional clusters: (i) the left 
region which harbors genes necessary for packaging of DNA and assembly of virus 
particles, (ii) the central region which harbors genes for recombination and lysogenic 
infection and finally (iii) the right region containing genes for DNA replication and 
lysis of host bacteria. The central region is not necessary for lytic infection and can thus 
be removed in λ-phage vectors to make room for a DNA insert. The central region also 
harbors the genes for recombination.  Removing this part effectively makes the λ-phage 
a rec- cloning vector. In phage particles the genome is linear. However, upon entering 
the host bacteria the cohesive single stranded termini of the genome is sealed by the 
host ligase, creating a circular genome (Wu & Taylor, 1971). During lytic infection 
DNA replication of the λ-phage genome alternates between theta replication and rolling 
circle mode. After injection into the host cell the now circular genome goes through 
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approximately 50 rounds of theta replication. Thereafter, it shifts to rolling circle mode 
creating tandem polymers of λ-phage genomes. These concatemers are then cut up and 
single genomes packaged into virus particles. The host bacterium is then lysed and the 
phage particles within it diffuse to infect new bacteria. The lytic cycle takes about 45 
minutes and generates approximately 100 virus particles per infected bacterium. When 
phages infect host bacteria grown as a lawn on an agar plate the clonal expansion of a 
single phage generates transparent plaques where the host cells have been lysed. These 
plaques can be picked and DNA extracted for analysis of single clones.   
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SPECIFIC AIMS 
Paper I: To investigate mtDNA mutations in an in vivo system by the use 
of NGS. More specifically, this was done in an effort to elucidate the distribution and 
origin of mtDNA mutations in mice.  
Paper II: To investigate how pathogenic mtDNA mutations are 
inherited. More specifically, to examine how human equivalent pathogenic tRNA 
mtDNA mutations are inherited in an in vivo system and whether there is selection 
against these mutations.   
Paper III: To investigate the role of mtDNA mutations in the aging 
process. More specifically, we wanted to examine the effects of germline inherited 
mtDNA mutations on the aging process  
Paper IV: To investigate whether mtDNA recombines. More 
specifically, by direct cloning and sequence analysis we wanted to investigate whether 
recombinant mtDNA molecules are created and passed on via the maternal germline in 
mammals.  
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RESULTS AND DISCUSSION 
 
ON SOMATIC mtDNA MUTATIONS AND AGING 
In paper I we show that somatic mutations in mtDNA are created by replication errors 
and not oxidative damage. We also show that mtDNA mutations are passed on via the 
germline to the offspring and that there is a huge variation in mutation accumulation 
between different nucleotide positions in mtDNA. Some site accumulated 100-1000 
time more mutations than others, clearly showing the presence of mutational hotspots 
in mtDNA. We failed to detect any increase in mutation load with increasing age in any 
of the mice used in this study.  
To date there is no universally accepted method for accurate quantification of 
somatic/low heteroplasmy mtDNA mutations. The development of NGS platforms 
might offer an opportunity to overcome these methodological shortcomings as they 
generate sequence data with incredible depth. These platforms are all based upon 
parallel amplification and sequencing of millions of DNA molecules, generating data at 
the single molecule level. In theory, this should enable identification of single 
molecules and unique mutations when sufficient sequencing depth is applied. However, 
NGS platforms tend to have a high inherent error rate, which up until recently has 
hindered their application for identification of somatic and low frequency mutations.  
We hypothesised that by using the SOLiD NGS platform (with the lowest error rate at 
that time point) in combination with a control for method induced artifacts (in the form 
of a Lambda cloned mtDNA molecule) that we could control for the high error rates 
and utilize the SOLiD NGS platform to detect and analyze somatic and low 
heteroplasmy mtDNA mutations.  
To investigate the mtDNA mutation spectrum in mice we used both mtDNA mutator- 
and wt mice. We set up the standard cross (an intercross between a PolGmut/+ male and 
female, see fig 3) to generate offspring with the following genotypes: (i) mice 
homozygous for WT PolG (PolG+/+) (ii) mice heterozygous for the mutator allele 
(PolGmut/+) and (iii) mice homozygous for the mutator allele (PolGmut/mut). DNA from 
two mice, 30 and 40 weeks of age, of each genotype were sequenced. We also used 
C57Bl/6 WT mice of 30, 40 and 84 weeks of age, henceforth denoted WT. Finally we 
used a clonally amplified WT mtDNA molecule (cloned into λ-phage) with a known 
sequence, henceforth denoted λmtDNA. This sample was sequenced as a step to control 
for method induced errors. All novel mutations found in this sample can be regarded as 
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sequencing errors as we know the input sequence. Thus, all mutations found in λmtDNA 
sample were subtracted from the actual samples.  
We extracted mtDNA from liver from mice of respective genotypes and age for 
sequencing on the SOLiD NGS platform. The samples were directly sequenced without 
any prior amplification. This was done to avoid PCR induced artifacts. We obtained 
sequence data for all of the samples with coverage of at least 1800x per bp. The 
coverage was evenly distributed among the bp for all of the samples except for the 
PolGmut/mut  mice. In these two samples there was a sharp reduction in coverage in the 
minor arc located between the two origins of replication. This decrease in coverage is 
most likely a consequence of the reported linear deleted molecules that constitute 
approximately 25-30 % of the mtDNA pool in the PolGmut/mut mice (Trifunovic, 
Wredenberg, Falkenberg, et al., 2004). No difference in mutation load was observed 
between the minor arc and the major arc, implying that the mutation load in the deleted 
mtDNA molecules is similar to the non-deleted mtDNA molecules. 
The mutation load was similar in WT and PolG +/+ mice, with between 1.3-1.8*10^-4 
mutations per bp. The PolGmut/+ had a slightly increased mutation load compared to 
PolG+/+ and WT mice, with between 3.3-3.8*10^-4 mutations per bp. The PolGmut/mut had 
a substantially higher mutation load compared to the other genotypes, with 11.7-
12.5*10^-4 mutations per bp. We also investigated the presence of high frequency 
mutations (defined as mutations with a heteroplasmy level >0.5 %) in the different 
genotypes. Interestingly there was an equal number of high frequency mutations in 
PolG+/+ and PolGmut/+ mice, implying that these were inherited via the germline. WT 
animals had only half the number of high frequency mutations compared to PolG+/+ 
mice. The mutation load in the PolGmut/mut mice was similar in protein coding genes, 
tRNAs and rRNAs. There was however a sharp reduction in mutation load within the 
control region. This was most pronounced in the CSBs, which had an 80 % reduction in 
mutation load compared to the coding regions. This implies that the control region is 
very sensitive to mutations. This is maybe not that surprising as OriH, LSP and HSP is 
located within this region. This finding goes in line with other reports, finding that 
some nucleotide positions within OriL are impossible to mutate due to their essential 
function in mtDNA replication (Wanrooij, Fusté, Stewart, et al., 2012).  
To elucidate the molecular origin of the mutations we mapped the number and ratio of 
transitions and transversions in the samples. Mutations generated by oxidative damage 
are expected to increase the number of transversions, exemplified by the common 
oxidative product 8-oxo-guanine, which generates G>T transversions when replicated 
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(Schmitt, Kennedy, Salk, et al., 2012). We could not detect an increase in transversions 
by increasing age in any of the samples, implying that oxidative damage is not the 
major mutagenic force in mitochondria. This argues against the vicious cycle that has 
been proposed to drive somatic mutagenesis (Harman, 1955) and instead suggests that 
replication errors are the causative factor. There was a great variation in mutation 
accumulation between different nucleotide positions, with some positions experience 
100-1000x more mutations than others, clearly showing the presence of mutational 
hotspots in mtDNA.   
We did not to detect any increase in mutation load with increasing age in any of the 
samples. This finding could argue against a role of mtDNA mutations in the aging 
process. However, an alternative explanation is that this increase in mutation load was 
too low to be detected by our method. This could be due to at least three reasons. First, 
aging is associated with polyclonal expansion of many different low-level mtDNA 
mutations (Park & Larsson, 2011).The mean heteroplasmy level of a specific mutation 
therefore becomes very low in the tissue as a whole, making it difficult to detect by 
sequencing of an entire tissue. Secondly, we only sequenced liver DNA. The results 
might have been different with another tissue such as heart or skeletal muscle. Thirdly, 
the error rate might have been too high, obscuring a subtle increase in mutation load by 
increasing age. We tried to minimize the error rate by using the SOLiD platform and a 
control sample. We did however obtain a mutation load estimate for WT mice (1.3-
1.8*10^-4 mutations per bp) that was an order of magnitude higher than estimates 
obtained by direct cloning (1*10^-5 mutations per bp, Sato, Nakada, Akimoto, et al., 
2005) which is supposed to be the most error free method. A methodological 
improvement that could have been applied is to score mutations as true only if they had 
been found on both strands. This was applied by Li, Schönberg, Schaefer, et al., 2010  
and was reported to lower the error rate 30 fold.     
 
ON mtDNA MUTATIONS AND INHERITANCE 
In paper II we show that the heteroplasmy level of pathogenic mtDNA mutations 
located in tRNA genes is determined prenatally during early germline development. 
We also show that there is a skewed heteroplasmy level distribution in the offspring 
from mothers with high heteroplasmy levels, consistent with purifying selection against 
these mutations.    
tRNAs constitute only 9 % of mtDNA in humans, but 58 % of the known pathogenic 
human mtDNA mutations are located in these genes (Stewart, Freyer, Elson, et al., 
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2008). Pathogenic mutations tend to be heteroplasmic and functionally recessive. To 
cause mitochondrial disease the mtDNA mutation load often has to reach a certain 
heteroplasmy level (around 70-80 %) and once this threshold is passed the level of the 
pathogenic mutations determines the severity of the disease. The heteroplasmy level 
among children from the same mother can vary enormously. Hence, an unaffected 
mother carrying a pathogenic mutation can give birth to both healthy and severely sick 
children. To date there is no way to counsel prospective mothers whether their children 
will be healthy or develop mitochondrial disease. These rapid shifts in heteroplasmy 
between generations have been explained by the mitochondrial bottleneck (Olivo, 
Walle, Laipis, et al., 1983). The bottleneck has been suggested to be caused by either a 
sharp reduction in mtDNA copy number (Cree, Samuels, de Lopes, et al., 2008) or by 
replication of a subpopulation of mtDNAs during germline development (Wai, Teoli & 
Shoubridge, 2008). However, the precise timing of these changes remains controversial 
and it is not clear whether selection has a role during transmission of pathogenic 
mtDNA mutations. These issues are important for the genetic counseling of prospective 
mothers and for the development of treatments aimed at disease prevention. 
Unfortunately this is a difficult topic to study in humans and the lack of appropriate 
animal models has hindered progress in this field.  
To address this important issue we generated a mouse model carrying a human 
equivalent pathogenic mtDNA mutation. This was done by backcrossing females 
homozygous for the mtDNA mutator allele (PolGmut/mut) to WT males to generate 
maternal lineages carrying different spectrums of mtDNA mutations. One of the 
lineages carried two mutations in its mtDNA: a m5245T<C substitution in tRNACys and 
a m3875delC deletion in tRNAMet. The m5245T<C mutation segregated to 
homoplasmy without any obvious phenotypic effects. The m3875delC mutation 
remained heteroplasmic with no offspring having a heteroplasmy level of >86 %, 
implying purifying selection against the mutation.  
To investigate this in more depth we quantified heteroplasmy levels in 533 offspring 
born to 44 different mothers. If there is no selection and the mutations are transmitted 
by random genetic drift the mean heteroplasmy level in the offspring should be the 
same as the heteroplasmy of the mother and follow a Kimura distribution. However, 
offspring from mothers with a heteroplasmy level of >40 % showed a significant 
deviation from the Kimura distribution and neutral transmission. As the high 
heteroplasmy mothers had the same number of surviving offspring the lack of >86 % 
offspring was not due to elimination of sick pups. Hence, some sort of purifying 
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selection against the m3875delC mutation took place. To investigate this further we 
crossed the mouse line to a reporter mouse (Stella-GFP), which expresses GFP in the 
germ cells. This enables isolation of single germ cells via FACS sorting, generating the 
possibility to quantify heteroplasmy levels of single germ cells. We measured the 
heteroplasmy level in 819 PGCs from 18 embryos at 13.5 d.p.c. We found a huge 
variation in heteroplasmy level among the PGCs, with some cells carrying the 
m3875delC mutation in homoplasmic state. The distribution of mutations in the PGCs 
was in line with random genetic drift and was in stark contrast to the pattern observed 
in the offspring. We then studied the heteroplasmy level in 340 oocytes isolated from 5 
different neonate animals at 3.5 days of age. Also here the distribution of heteroplasmy 
among the cells was in line with random genetic drift, indicating that no selection had 
taken place. As a final test to address when selection occurs, we calculated the 
heteroplasmy level difference between the mother and the PGCs, oocytes and the 
offspring. A negative correlation between the mother´s heteroplasmy level and the 
heteroplasmy level in the PGC, oocyte or offspring indicates selection. Only the 
offspring showed such a correlation.  
The m3875delC mutation does cause a conformational change of the tRNAMet, 
resulting in amino-acylation defects in heart and muscles of these mice. However, we 
could not detect any defects in mitochondrial respiration or enzymatic activities. This is 
might be explained by increased transcription and protein levels in these mice, masking 
the effects of the mutation. A similar compensatory effect has been seen in other mouse 
models with translational defects (Metodiev, Lesko, Park, et al., 2009). 
The results from this study show us two important things regarding mtDNA mutation 
inheritance and selection: (i) that the heteroplasmy level variation for tRNA mtDNA 
mutations is set early during germline development and (ii) that there is no selection 
against pathogenic tRNA mtDNA mutations in the germline, but rather in the offspring. 
A previous study (Stewart, Freyer, Elson, et al., 2008) found that tRNAs accumulate a 
similar amount of mutations as third codon positions in protein coding genes, indicating 
relaxed selection in tRNA genes. Furthermore, as the majority of pathogenic mtDNA 
mutations are located in tRNA genes it has been assumed that there is no or very little 
selection against mutations in these genes. The findings in this study contradict this, 
showing clear signs of selection against the tRNA mutation.  The finding that selection 
takes place in the offspring argues against the involvement of artresia in the purging of 
pathogenic mtDNA mutations. If atresia functions as a selective filter (removing 
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oocytes with pathogenic mtDNA mutations) we should see a skew in heteroplasmy 
distribution among the oocytes. This was not the case.  
 
ON GERMLINE mtDNA MUTATIONS AND AGING 
In paper III we show that low levels of maternally inherited mtDNA mutations can 
induce premature aging and reduced fertility in mice. These phenotypes can be reversed 
by introduction of WT mtDNA, clearly showing the role of inherited mtDNA 
mutations in inducing these phenotypes. Furthermore, we show that a combination of 
somatic mutagenesis and inherited mtDNA mutations can lead to the development of 
brain malformations.  
Our group has previously shown that an increase in somatic mtDNA mutation load can 
cause the development of a progeroid phenotype in mice (Trifunovic, Wredenberg, 
Falkenberg, et al., 2004). However, what has been less clear is what role inherited 
mtDNA mutations have in the aging process. Furthermore, it has recently been shown 
that low level heteroplasmy is universal in humans and that a significant part of these 
mutations are inherited via the germline (Payne, Wilson, Yu-Wai-Man, et al., 2012). 
This finding makes elucidating the effect of inherited mtDNA mutations in aging a 
matter of great interest and importance.  
To address this subject we used the mtDNA mutator mouse (Trifunovic, Wredenberg, 
Falkenberg, et al., 2004; Kujoth, Hiona, Pugh, et al., 2005). This knock in mouse 
model has an increased mtDNA mutation load due to a proofreading deficiency in PolG 
and develops a progeroid phenotype. We have shown that females heterozygous for the 
mutator allele (PolGmut/+) transmit a significant amount of mtDNA mutations via the 
germline to the offspring (Ameur, Stewart, Freyer, et al., 2011). We set up matings to 
generate mice that differed both in their mtDNA mutation load but also to what extent 
these mutations were inherited, generated somatically or both (Fig 3). We used the 
standard mutator mating (intercross between PolGmut/+ male and female) to generate 
offspring with three different genotypes: type I mice (PolG+/+), type II mice (PolGmut/+) 
and type III mice (PolGmut/mut). Type I, II and III mice all carry mtDNA mutations 
inherited via the germline, in addition to the somatically generated mtDNA mutations 
in type II and III mice (type I lacks somatic mutations as it carries WT nDNA). (Type I-
III animals are the same genotypes as in paper I, but due to the great number of 
different mice used in this paper we had to rename them). We also set up a second 
mating (between a PolGmut/+ males and a PolG+/+ females) to generate offspring with 
the following genotypes: type IV mice (PolG+/+) and type V mice (PolGmut/+). Both type 
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IV and V mice lack germline inherited mtDNA mutations and only carry somatic 
mutations. Finally we set up a mating between a PolGmut/+ male and a PolGKO/+ female 
to generate type VI mice (PolGmut/KO). Type VI mice are functionally homozygous for 
the mutator allele but lack germline inherited mutations.  
 
 
 
Figure 3. Showing the crosses used to generate mice with different genotypes for PolG. The 
mice will differ in mtDNA mutation load but also to what extent mutations are inherited via the 
germline, generated somatically or both (see list in figure). The genotypes generated from cross 
a were used in paper I and the genotypes generated from cross a, b and c were used in paper III.  
a, intercross of mice heterozygous for the mutator allele (PolGmut/+) to generate type I-III mice. 
These mice all have mutations passed on via the germline but differ in somatic mutagenesis. b, 
cross between PolGmut/+ male and PolG+/+ female. The offspring from this cross will lack 
germline inherited mutations. This was the mating strategy used in paper III to reintroduce WT 
mtDNA. c, cross between a PolGmut/+ male and PolGwt/KO female generating PolGmut/KO 
offspring. These mice are functionally homozygous for the mutator allele but lack germline 
inherited mutations. (Figure from Ross et al. 2013, Nature doi 10.1038/nature12474).     
 
Continuous intercrossing of PolGmut/+ animals for several generations resulted in 
reduced fertility in the form of fewer and smaller litters and less PolGmut/mut mice in the 
offspring. However, when WT mtDNA was re-introduced to the mice (by using a 
PolG+/+ female, Fig. 3, cross b) these phenotypes was rescued and almost reverted to 
WT levels. Continuous intercrossing of mice without re-introduction of WT mtDNA 
thus leads to a progressive decline in fertility. Reintroducing WT mtDNA via the male 
did not rescue these phenotypes, clearly showing the role of mtDNA mutations in 
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inducing these phenotypes. To further investigate the role of germline inherited 
mtDNA mutations in the aging process we compared the phenotypes of three different 
types of PolG+/+ mice: wtN-1 mice (generated from an intercross using a PolGmut/+  
female, thus carrying mtDNA mutations inherited via the maternal germline), wtN-2 
(generated from an intercross using a mother with reintroduced WT mtDNA, thus 
carrying mtDNA with mutation load close to WT levels) and finally wtN-3 mice 
(generated from a intercross between a PolGmut/+  female and a male with reintroduced 
WT mtDNA, thus having same mtDNA mutation load levels as the wtN-1 mice). The 
wtN-3 mice function as controls to ensure that any observed phenotypic differences 
between the wtN-1 and wtN-2 mice are due to mutations in mtDNA and not due to the 
influence of nDNA. WtN-1 and wtN-3 mice showed significant weight reduction and 
signs of premature aging at 65 weeks of age. At this time point wtN-2 mice showed 
virtually no signs of aging. However, continuous intercrossing of type wtN-2 mice to 
PolGmut/+ mice resulted in a similar phenotype as the wtN-1 and wtN-3 mice. The similar 
phenotypes in wtN-1and wtN-3 mice show the role of mtDNA mutations in the 
development of these phenotypes.   
To investigate the genetic and molecular basis of the detected phenotypes we 
sequenced mtDNA from several animals of the respective genotypes. We applied two 
different strategies to obtain mtDNA sequence data: (i) PCR-and cloning and (ii) λ-
phage direct cloning. The PCR-and cloning approach has been criticized for 
introducing artifacts as it tends to generate higher mutation load estimates than other 
methods (Greaves, Beadle, Taylor, et al., 2009; Alex, Kraytsberg, Khrapko, et al., 
2007). The problem with the cloning procedure is that it renders artifacts introduced by 
the PCR polymerase indistinguishable from true mutations .To correct for this we also 
used direct cloning by λ-phage to estimate the mutation load and spectrum. Direct 
cloning is supposed to be the methodological approach with the lowest error rate (Alex, 
Kraytsberg, Khrapko, et al., 2007;  Edgar, Larsson & Trifunovic, 2010). The estimates 
from the two different methods were in good concordance for all genotypes, implying 
that artifacts do not confound our data. The sequence data showed a significant increase 
of clonally expanded mtDNA mutations in type I, II and III animals, compared to type 
IV, V and VI mice. Hence, mutations inherited via the germline expand clonally, most 
likely as a consequence of passing through the mitochondrial bottleneck. To study this 
further, we generated a single burst of mutations in the female germline by using 
PolGmut/+ females. We crossed the offspring to wt animals and sequenced mtDNA from 
several consecutive generations. From generation N2 and onwards mutations were 
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detectable from bulk sequencing of a tissue (this is a consequence of that the mutations 
had expanded clonally to higher and detectable levels). It is also from the N2 
generation and onwards that mutations start to generate a phenotype in the both the 
PolGmut/+ and wtN-2 mice. This clearly shows the importance of clonal expansion for 
mtDNA mutations to have a phenotypic effect.   
We continued to investigate the role of inherited and somatically generated mtDNA 
mutations in the aging process by detailed phenotyping of PolG- mut/mut and PolGmut/KO 
mice. We compared the mean lifespan of PolGmut/mut mice generated from a standard 
cross and from a cross where the mother carried re-introduced wt mtDNA. The latter 
mice had a mean lifespan that was approximately 10 weeks longer than the former, 
clearly showing the influence of inherited mtDNA mutations in aging. We also did a 
detailed phenotyping of type III and type VI mice. At 35 weeks of age they both 
showed weight loss, reduced hemoglobin concentration and erythrocyte count. 
However they also differed in some other important aspects. Type III had more 
pronounced heart enlargement than type VI mice. Heart cells in type III mice also 
showed reduced COX enzyme activity. This was also true for colonic crypts, where the 
number of COX deficient cells was significantly higher in type III mice than in type VI 
mice. The finding that mice with inherited mtDNA mutations have more COX deficient 
cells makes sense in light of the results from sequence data. It shows that inherited 
mtDNA mutations can expand clonally, to create heteroplasmy levels high enough to 
cause a biochemical defect in cells.  
Furthermore, 32 % of type III mice developed stochastic brain malformations. These 
were not present in any of the other types of mice, showing that a dual hit of inherited 
mtDNA mutations and somatic mutagenesis is required for these brain malformations 
to occur.  
 
ON mtDNA AND RECOMBINATION 
In paper IV we show that mtDNA in the mammalian germline does not undergo 
recombination and that mtDNA is inherited clonally. We could also show that a new 
direct cloning protocol we have developed can trap single whole mtDNA molecules 
without biasing towards specific molecules or introducing artifacts. By using this direct 
cloning approach to isolate single mtDNA molecules from a long term heteroplasmic 
mouse line were could address the important question of mtDNA recombination in the 
mammalian germline without suffering from the common limitations of direct test for 
recombination.  
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mtDNA is assumed to be inherited in a clonal fashion, lacking germline recombination. 
This trait has made mutations in mtDNA the most widely used marker in population 
genetic studies. However, clonal inheritance and lack of recombination in mtDNA has 
now been questioned in a number of studies (Zsurka, Kraytsberg, Kudina, et al., 2005; 
Kraytsberg, Schwartz, Brown, et al., 2004; Fan, Lin, Potluri, et al., 2012; D’Aurelio, 
Gajewski & Lin, 2004; Ujvari, Dowton & Madsen, 2007; Awadalla, Eyre-Walker & 
Smith, 1999; Hagelberg, Goldman, Lió, et al., 1999) reporting either the identification 
of recombinant mtDNA molecules or signs of recombination in population genetic 
mtDNA sequence data. These findings, if true, could have profound effects on the 
interpretation of phylogenetic studies as even a limited amount of recombination has 
been shown to affect coalescent time estimates and branch lengths in phylogenetic trees 
(Schierup & Hein, 2000). However, there are two general problems with mtDNA 
recombination studies: (i) they mostly cover somatic events which are irrelevant to 
evolution and (ii) they often use PCR, thus introducing the risk of creating artificial 
recombinants. We were able to circumvent these problems by direct cloning of mtDNA 
molecules from a longterm heteroplasmic mouse line. This mouse line used was 
generated by cytoplasmic transfer >20 years ago (Jenuth, Peterson, Fu, et al., 1996) and 
is artificially heteroplasmic for the NZB and BALB/c mtDNA genotypes. These 
genotypes differ at 90 nucleotide positions, which are evenly distributed in the 
mitochondrial genome. As this mouse line has been heteroplasmic for a defined set of 
mutations for >50 generations, it allows us to use present genetic variation to screen for 
recombination during this entire time period. Hence, we could use a direct test to screen 
for mtDNA recombination in the germline without suffering from the limitations of 
genetic drift and lineage extinction. Furthermore, the even distribution of the 90 SNP 
where the NZB and BALB/c genotypes differ should make it possible to differentiate 
between homoplasies and recombination. Homoplasies should result in single base pair 
similarities and recombination in multiple similarities distributed over a longer stretch 
of DNA.  
Direct tests of recombination demand the isolation and analysis of single mtDNA 
molecules. This is most often obtained by cloning of PCR products. This approach is 
however highly unsuitable for recombination studies as PCR has been shown to create 
artificial recombinant molecules in vitro (Pääbo, Irwin & Wilson, 1990; Keohavong & 
Thilly, 1989) and the cloning step makes the distinction between artefacts and true 
recombinants impossible. We could in this study also show frequent creation of 
artificial recombinants by PCR. We have previously applied a standard PCR-Clone-
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Sequence protocol to detect mtDNA mutations in C57BL/6N mice (Wanrooij, Fusté, 
Stewart, et al., 2012). From this available dataset we extracted sequences that had been 
filtered due to similarity with nuclear mtDNA pseudogenes (NuMts). We identified 
NuMts in 41 of 3940 clones (~1% of samples). Nine of the clones showed evidence of 
8 independent PCR-induced recombination events between NuMts and mtDNA. This 
high frequency was present despite the very low abundance of nuclear DNA relative to 
mtDNA in the samples, clearly showing how unsuitable PRC and cloning is for 
recombination studies. A more stringent methodological approach that has been applied 
in one study is direct cloning of parts of mtDNA molecules (Sato, Nakada, Akimoto, et 
al., 2005). Direct cloning omits PCR amplification prior to cloning and thus 
circumvents the problem of PCR induced artificial recombinants. However, a problem 
with the Sato, Nakada, Akimoto, et al., 2005 study is that almost exclusively 
investigates somatic recombination. We wanted to apply direct cloning to screen for 
mtDNA recombination in the germline of mammals. For this purpose we utilized the λ-
phage. After setting up a well functional protocol that enabled us to clone whole 
mtDNA molecules we carried out method verification experiments. We experimentally 
tested that the method was unbiased towards which molecules that were being cloned, 
that it had a low error rate and that it did not create artificial recombinants molecules.  
To screen for recombination we extracted mtDNA from liver and kidney from two 
NZB-BALB/c animals and cloned it into the λ-phage, followed by RFLP analysis of 
2992 molecules. Each genotype generates a specific cleavage pattern in the RFLP 
analysis. We therefore screened for molecules generating a mixed pattern, indicative of 
recombination.  We detected one molecule showing a mixed NZB and BALB/c 
cleavage pattern. However upon sequencing the entire molecule only one single 
nucleotide position was changed (m15657C > T) indicating that this change was a 
homoplasy, rather than a recombination event. In total we screened 70,128 bp of 
mtDNA by RFLP and identified a single mutation. This gives a mutation load of 
~1.43x10-5 mutations per bp. This mutation load is in good concordance with the 
mutation load estimate obtained by PCR-clone-sequencing and λ-phage cloning 
(unpublished data). Furthermore we sequenced 8 NZB and 9 BALB/c molecules. This 
did not reveal any recombinant molecules.  
In summary, we used direct cloning of whole mtDNA molecules from a long term 
heteroplasmic mouse line to show that mtDNA in the germline of mammals does not 
undergo recombination under biological and evolutionary relevant conditions and that 
mtDNA is inherited in a clonal manner.  
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